Table 1.
Cardiorenal and humoral function
Baseline | Δ with BNP 8-32 | Δ with BNP 1-32 | P value† | |||||
---|---|---|---|---|---|---|---|---|
Hemodynamic function | ||||||||
Heart rate, beats/min | 123±12 | +7±3* | +17±5* | 0.15 | ||||
Right atrial pressure, mmHg | 1.3±0.4 | −0.5±0.2* | −0.8±0.3* | 0.39 | ||||
Pulmonary artery pressure, mmHg | 12.6±0.7 | −1.2±0.7 | −0.5±0.4 | 0.33 | ||||
Pulmonary capillary wedge pressure, mmHg | 4.2±0.6 | −0.9±0.3* | −1.5±0.4* | 0.31 | ||||
Cardiac output, l/min | 4.0±0.2 | −0.4±0.3 | −0.1±0.1 | 0.44 | ||||
Systemic vascular resistance, mmHg·l−1·min | 33±2 | +1.5±2.0 | +0.5±0.8 | 0.67 | ||||
Renal vascular resistance, mmHg·l−1·min | 432±37 | −55±23* | −81±20* | 0.18 | ||||
Renal function | ||||||||
Glomerular filtration rate, ml/min | 47±6 | +9±3* | +10±5 | 0.67 | ||||
Urinary potassium excretion, μEq/min | 23±3 | +28±4* | +48±4* | 0.02 | ||||
Humoral function | ||||||||
Hematocrit, % | 40±1 | +0.9±0.9 | +3.2±0.4* | 0.09 | ||||
Atrial natriuretic peptide, pg/ml | 11±1 | +5±1* | +5±1* | 0.74 | ||||
Plasma renin activity, ng·ml−1·h−1 | 9.9±1.6 | −4.5±0.9* | −2.2±0.7* | 0.10 | ||||
Angiotensin II, pg/ml | 12.5±2.9 | −4.3±2.5 | −0.4±0.9 | 0.13 | ||||
Aldosterone, ng/dl | 10.5±2.4 | +4.9±6.2 | −2.6±1.2 | 0.22 | ||||
Plasma sodium, mmol/l | 145±1 | +0.7±1.0 | +2.1±0.9 | 0.34 | ||||
Plasma potassium, mmol/l | 4.1±0.1 | −0.0±0.1 | −0.0±0.0 | 0.91 |
Values are expressed as means ± SE. Baseline denotes levels during the first clearance before any peptide infusion
P < 0.05 vs. respective preinfusion level.
P value for comparison of changes from respective preinfusion levels induced by BNP 8-32 vs. BNP 1-32. BNP, B-type natriuretic peptide; Δ, change from preinfusion level.